Related references
Note: Only part of the references are listed.Pathological Conditions Involving Extracellular Hemoglobin: Molecular Mechanisms, Clinical Significance, and Novel Therapeutic Opportunities for α1-Microglobulin
Magnus G. Olsson et al.
ANTIOXIDANTS & REDOX SIGNALING (2012)
Economic assessment of screening for pre-eclampsia
Amir Shmueli et al.
PRENATAL DIAGNOSIS (2012)
Hypertension in pregnancy: the NICE guidelines
C. W. G. Redman
HEART (2011)
Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by α1-microglobulin
K. May et al.
PLACENTA (2011)
Toxicological Consequences of Extracellular Hemoglobin: Biochemical and Physiological Perspectives
Paul W. Buehler et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger α1-microglobulin in preeclampsia
Magnus G. Olsson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension.
James M. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Feto-maternal interactions in pregnancies: Placental microparticles activate peripheral blood monocytes
M. Messerli et al.
PLACENTA (2010)
First-trimester maternal plasma cell-free fetal DNA and preeclampsia
Stavros Sifakis et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Disseminated intravascular coagulation in obstetric disorders and its acute haematological management
Jecko Thachil et al.
BLOOD REVIEWS (2009)
Maternal Circulating Levels of Activin A, Inhibin A, sFlt-1 and Endoglin at Parturition in Normal Pregnancy and Pre-Eclampsia
Aparna Reddy et al.
PLOS ONE (2009)
Perfusion of the Human Placenta with Red Blood Cells and Xanthine Oxidase Mimics Preeclampsiain-vitro
M. Centlow et al.
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE (2009)
Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion
Holger Stepan et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Preeclampsia and angiogenic imbalance
Sharon Maynard et al.
ANNUAL REVIEW OF MEDICINE (2008)
Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years
Anne Andermann et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis
Jeltsje S. Cnossen et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes
Magnus Centlow et al.
FERTILITY AND STERILITY (2008)
The lipocalin alpha(1)-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species
Magnus G. Olsson et al.
FREE RADICAL RESEARCH (2008)
Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation
M. D. Savvidou et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia
Zhihe Li et al.
HYPERTENSION (2007)
Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
Holger Stepan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia
Corinne Rusterholz et al.
SEMINARS IN IMMUNOPATHOLOGY (2007)
Up-regulation of α1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines
Magnus G. Olsson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells
Hong-Wa Yung et al.
FASEB JOURNAL (2007)
Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
Anna-Karin Wikstom et al.
OBSTETRICS AND GYNECOLOGY (2007)
First trimester screening for preeclampsia
Aris T. Papageorghiou et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA
May Lee Tjoa et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Hemoglobin and heme scavenging
P Ascenzi et al.
IUBMB LIFE (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The myometrial junctional zone spiral arteries in normal and abnormal pregnancies - A review of the literature
JJ Brosens et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia
S Hahn et al.
HUMAN REPRODUCTION UPDATE (2002)
Processing of the lipocalin α1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties
M Allhorn et al.
BLOOD (2002)
Identification of the haemoglobin scavenger receptor
M Kristiansen et al.
NATURE (2001)
Nitric oxide dysfunction in the pathophysiology of preeclampsia
DT Lowe
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2000)
Share Paper
